-
College health centers and certain family planning clinics who looked to reduced pricing on contraceptives from manufacturers had to regroup when the 2005 federal Deficit Reduction Act (DRA) tightened eligibility for nominally priced drugs.
-
Is information on breast self-exams (BSEs) included in your care of women? Findings from a 2009 study indicate that a brief intervention program based on a single counseling session and two follow-up phone calls significantly increased the number of women correctly performing such exams.
-
Plan to get the latest information on family planning issues at three fall conferences. All three events will cover cutting-edge material on contraceptive practices and will offer continuing education credits.
-
In the past half century, technology, environmental awareness, and modern science have surged. Yet, as in all generations, a significant number of consumers, perhaps intent upon getting back to simpler times, are choosing "healthful" therapies not fully accepted by the mainstream.
-
-
-
NSAIDs in the elderly; managing GI and CVD risk with NSAIDs; low-dose naltrexone and fibromyalgia; treating glucocorticoid-induced bone loss; FDA Actions.
-
When it comes to emergency contraception (EC), placement of a Copper T 380A intrauterine device [(IUD), ParaGard, Duramed Pharmaceuticals, a subsidiary of Barr Pharmaceuticals; Pomona, NY] offers excellent protection against unwanted pregnancy, as well as long-term contraception. What are some of the roadblocks that may hinder its use?
-
The Food and Drug Administration (FDA) has approved two new tests for human papillomavirus (HPV). How does the addition of these tests affect current practice?
-
During his 2008 campaign and in the budget framework that President Obama sent to Congress late in February, he signaled his support for a U-turn in federal policy to prevent pregnancy and sexually transmitted infections (STIs) among American youth.
